16
Views
9
CrossRef citations to date
0
Altmetric
Original Articles

Hypercalcemia

Mechanisms, differential diagnosis, and remedies

, MD, JD
Pages 119-126 | Published online: 30 Jun 2015

Selected readings

  • Bilezikian JP. Parathyroid hormone-related peptide in sickness and in health. (Editorial) N Engl J Med 1990; 322(16):1151–3
  • Boisaubin EV, Lynch GR, Dresser R. Hypercalcemia of advanced malignancy: decision making and the quality of death. Am J Med Sci 1991; 301(5): 314–8
  • Brandt DW, Burton DW, Gaidar AF, et al. All major lung cancer cell types produce parathyroid hormone-like protein: heterogeneity assessed by high performance liquid chromatography. Endocrinology 1991; 129(5):2466–70
  • Burtis WJ. Parathyroid hormone-related protein: structure, function, and measurement. Clin Chem 1992: 38(11): 2171–83
  • Edelson GW, Kleerekoper M. Hypercalcemic crisis. Med Clin North Am 1995; 79(1): 79–92
  • Ikeda K, Ogata E. Humoral hypercalcemia of malignancy: some enigmas on the clinical features. J Cell Biochem 1995; 57(3): 384–91
  • Moseley JM, Gillespie MT. Parathyroid hormone-related protein. Crit Rev Clin Lab Sci 1995; 32(3): 299–343
  • Ralston SH. Medical management of hypercalcaemia. Br J Clin Pharmacol 1992; 34(1): 11–20
  • Wimalawansa SJ. Optimal frequency of administration of Pamidronate in patients with hypercalcaemia of malignancy. Clin Endocrinol (Oxf) 1994; 41(5): 591–5

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.